E.J. Read

2.3k citations
28 papers · 1.9k · h-index 16

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 2%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

  • Hematology 13
    • Hematopoietic Stem Cell Transplantation 13
  • Immunology 13
    • Immunotherapy and Immune Responses 7
    • T-cell and B-cell Immunology 7
    • Immune Cell Function and Interaction 4
Co-authors
C. Carter (4 shared papers)Susan F. Leitman (8 shared papers)Emmanuel Clave (3 shared papers)Erkut Bahceci (4 shared papers)Nancy F. Hensel (3 shared papers)Richard Childs (5 shared papers)Neal S. Young (3 shared papers)A. John Barrett (2 shared papers)
Journals
Cytotherapy (11 papers)Blood (6 papers)Bone Marrow Transplantation (3 papers)Journal of Clinical Oncology (1 paper)Nature Medicine (1 paper)
Partner nations
United StatesGermanyNetherlands

In The Last Decade

E.J. Read

28 papers receiving 1.9k citations

Peers

E.J. Read
Comparison fields: 5 of 88
  • Hematology 907
  • Immunology 979
  • Transplantation 85
  • Oncology 599
  • Genetics 144
Replace Yoshiki Akatsuka with:
Yoshiki Akatsuka Japan
Silvano Rossini Italy
BR Blazar United States
AP Gillio United States
K. F. Bradstock Australia
Boris Calmels France
S T Ildstad United States
J.W. Gratama Netherlands
Paolo Servida Italy
C. Carter United States
E.J. Read relative to Yoshiki Akatsuka Japan Yoshiki Akatsuka's profile →
Citations per field
00.5×1.5×
Yoshiki Akatsuka · 1×
Citations per year

Countries citing papers authored by E.J. Read

Since Specialization
Citations

This map shows the geographic impact of E.J. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.J. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.J. Read more than expected).

Fields of papers citing papers by E.J. Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.J. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.J. Read. The network helps show where E.J. Read may publish in the future.

Co-authors

The 25 scholars most cited alongside E.J. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.J. Read Line = papers co-authored together E.J. Read links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses
Blood ·Richard Childs, Emmanuel Clave, Nathalie Contentin, D. Jayasekera, Nancy F. Hensel, Susan F. Leitman, E.J. Read, C. Carter, Erkut Bahceci, Neal S. Young, A. John Barrett
1999449
2
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells
Nature Medicine ·Hua Zhang, Kevin Chua, Martin Guimond, Veena Kapoor, Margaret Brown, Thomas A. Fleisher, Lauren Long, Donna Bernstein, Brenna J. Hill, Daniel C. Douek, Jay A. Berzofsky, Charles S. Carter, E.J. Read, Lee J. Helman, Crystal L. Mackall
2005310
3
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
Journal of Clinical Oncology ·Beth Fisher, Beverly S. Packard, E.J. Read, Jorge A. Carrasquillo, C. Carter, S L Topalian, Jiacai Yang, P Yolles, S M Larson, S A Rosenberg
1989262
4
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies
Blood ·Dimitriοs Mavroudis, E.J. Read, Michele Cottler‐Fox, Daniel R. Couriel, Jeffrey J. Molldrem, C Carter, Mengmeng Yu, Cynthia E. Dunbar, Barrett Jc
1996213
5
In Vivo Distribution of Adoptively Transferred Indium- 111- Labeled Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes in Patients With Metastatic Melanoma
JNCI Journal of the National Cancer Institute ·Kean D. Griffith, E.J. Read, Jorge A. Carrasquillo, C. S. Carter, James C. Yang, Beth Fisher, Paul Aebersold, Beverly S. Packard, M. Y. Yu, S A Rosenberg
1989145
6
T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect
Bone Marrow Transplantation ·A. John Barrett, Dimitriοs Mavroudis, John F. Tisdale, Jeffrey J. Molldrem, Emmanuel Clave, Cynthia E. Dunbar, Michele Cottler‐Fox, Sonia Chew Wen Phang, C. Carter, P Okunnieff, NS Young, E.J. Read
1998119
7
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation
Cytotherapy ·Scott R. Solomon, Thuong Hien Tran, C. S. Carter, Sheila Donnelly, Nancy F. Hensel, John Schindler, Erkut Bahceci, Victor Gheţie, Jaroslav Michálek, Dimitriοs Mavroudis, E.J. Read, E S Vitetta, A. John Barrett
200251
8
Viability of platelets following storage in the irradiated state. A pair‐controlled study
Transfusion ·E.J. Read, C. Kodis, C. S. Carter, Susan F. Leitman
198849
9
A multicenter comparison study between the Endosafe® PTS™ rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products
Cytotherapy ·Adrian P. Gee, Darin Sumstad, Joanna Stanson, Paul D. Watson, Jo Lynn Proctor, D. Kadidlo, E. Koch, Jenessa Sprague, Deborah Wood, David Styers, David H. McKenna, Joseph F. Gallelli, D. B. Griffin, E.J. Read, Britt Parish, R. Lindblad
200847
10
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy
Cytotherapy ·Eitan Wong, V. Ellen Maher, Kenneth Hines, J. Lee, C.S. Carter, Theresa J. Goletz, William Kopp, Crystal L. Mackall, Jay A. Berzofsky, E.J. Read
200139
11
Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers
Cytotherapy ·Eitan Wong, S.M. Lee, Kenneth Hines, J. Lee, C.S. Carter, William Kopp, Julia Glade Bender, E.J. Read
200236
12
T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia
Bone Marrow Transplantation ·DA Mavroudis, E.J. Read, Jeffrey J. Molldrem, Anastasios Raptis, Michelle Plante, C. S. Carter, Sonia Chew Wen Phang, Cynthia E. Dunbar, A. John Barrett
199832
13
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences
Cytotherapy ·Hanh Khuu, Hanni Cowley, V. David-Ocampo, C.S. Carter, Claude Kasten-Sportès, Alan S. Wayne, Scott R. Solomon, Michael Bishop, Richard Childs, E.J. Read
200227
14
Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products
Cytotherapy ·Hanh Khuu, Frida Stock, M. McGann, C.S. Carter, James Wade Atkins, Patrick R. Murray, E.J. Read
200426
15
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation
Bone Marrow Transplantation ·Scott R. Solomon, Ryotaro Nakamura, E.J. Read, Susan F. Leitman, C Carter, Richard Childs, Cynthia E. Dunbar, Neal S. Young, A. John Barrett
200326
16
Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses
Blood ·Richard Childs, Emmanuel Clave, Nathalie Contentin, D. Jayasekera, Nancy F. Hensel, Susan F. Leitman, E.J. Read, C. Carter, Erkut Bahceci, Neal S. Young, A. John Barrett
199925
17
Phase I clinical trial of donor T-helper Type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant
Cytotherapy ·Daniel H. Fowler, Jeannie Hou, Jonathan E. Foley, Fran Hakim, Jeanne Odom, Kate Castro, C. Carter, E.J. Read, Juan Gea‐Banacloche, Claude Kasten-Sportès, Larry W. Kwak, Wendy Wilson, Bruce L. Levine, Carl H. June, Ronald E. Gress, Michael R. Bishop
200212
18
AMD3100 Mobilized Apheresis Products Are Rich in T-Cells That Do Not Undergo a Th-2 Type Cytokine Polarization: Implications for Allografting.
Blood ·Yoshiyuki Takahashi, Abdul Tawab, Roger Kurlander, Mohamed F. Elshal, Charles D. Bolan, E.J. Read, Susan F. Leitman, J. Philip McCoy, Andreas Lundqvist, Erkut Bahceci, Richard Childs
20056
19
Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy.
PubMed ·E.J. Read, Joyce O’Shaughnessy, Miao Yu, Michele Cottler‐Fox, Andrea Denicoff, Kenneth H. Cowan, Ronald E. Gress
19925
20
A Detailed Phenotypic Analysis Using Six Color Flow Cytometry of Lymphocyte Subsets Mobilized with AMD3100 Compared to G-CSF.
Blood ·Yoshiyuki Takahashi, Sakti Chakrabarti, R. Sriniivasan, Andreas Lundqvist, E.J. Read, Hanh Khuu, Susan F. Leitman, Charles D. Bolan, A. John Barrett, Gary Calandra, Richard Childs
20043

About E.J. Read

E.J. Read is a scholar working on Hematology, Immunology, Oncology, Surgery and Transplantation, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (13 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (907 citations), Immunology (979 citations), Transplantation (85 citations), Oncology (599 citations) and Genetics (144 citations). E.J. Read has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include C. Carter, Susan F. Leitman, Emmanuel Clave, Erkut Bahceci, Nancy F. Hensel, Richard Childs, Neal S. Young, A. John Barrett, Nathalie Contentin and Beverly S. Packard. Their work appears in journals such as Cytotherapy, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiki AkatsukaBreakdown of academic impact, for papers by Silvano RossiniBreakdown of academic impact, for papers by BR BlazarBreakdown of academic impact, for papers by AP GillioBreakdown of academic impact, for papers by K. F. BradstockBreakdown of academic impact, for papers by Boris CalmelsBreakdown of academic impact, for papers by S T IldstadBreakdown of academic impact, for papers by J.W. GratamaBreakdown of academic impact, for papers by Paolo ServidaBreakdown of academic impact, for papers by C. Carter